CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
复制标题
DOI:
10.1186/s12931-022-02119-1
复制
发表时间:
2022-07-28
影响因子:
5.8
通讯作者:
中科院分区:
文献类型:
--
作者:
CCAAT/Enhancer Binding Protein D (CEBPD), a pleiotropic glucocorticoid-responsive transcription factor, modulates inflammatory responses. Of relevance to asthma, expression of CEBPD in airway smooth muscle (ASM) increases with glucocorticoid exposure. We sought to characterize CEBPD-mediated transcriptomic responses to glucocorticoid exposure in ASM by measuring changes observed after knockdown of CEBPD and its impact on asthma-related ASM function. Primary ASM cells derived from four donors were transfected with CEBPD or non-targeting (NT) siRNA and exposed to vehicle control, budesonide (100 nM, 18 h), TNFα (10 ng/ml, 18 h), or both budesonide and TNFα. Subsequently, RNA-Seq was used to measure gene expression levels, and pairwise differential expression results were obtained for exposures versus vehicle and knockdown versus control conditions. Weighted gene co-expression analysis was performed to identify groups of genes with similar expression patterns across the various experimental conditions (i.e., CEBPD knockdown status, exposures). CEBPD knockdown altered expression of 3037 genes under at least one exposure (q-value < 0.05). Co-expression analysis identified sets of 197, 152 and 290 genes that were correlated with CEBPD knockdown status, TNFα exposure status, and both, respectively. JAK-STAT signaling pathway genes, including IL6R and SOCS3, were among those influenced by both TNFα and CEBPD knockdown. Immunoblot assays revealed that budesonide-induced IL-6R protein expression and augmented IL-6-induced STAT3 phosphorylation levels were attenuated by CEBPD knockdown in ASM. CEBPD modulates glucocorticoid responses in ASM, in part via modulation of IL-6 receptor signaling. The online version contains supplementary material available at 10.1186/s12931-022-02119-1.
登录
查看更多内容
DOI:
10.1038/nrrheum.2015.169
发表时间:
2016-01
期刊:
Nature reviews. Rheumatology
影响因子:
--
作者:
Kalliolias GD;Ivashkiv LB
通讯作者:
Ivashkiv LB
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
8.3
作者:
Nurmagambetov, Tursynbek;Kuwahara, Robin;Garbe, Paul
通讯作者:
Garbe, Paul
影响因子:
24.3
作者:
Chung, Kian Fan;Wenzel, Sally E.;Teague, W. Gerald
通讯作者:
Teague, W. Gerald
DOI:
10.1016/j.jaci.2012.03.018
发表时间:
2012-08
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Hawkins GA;Robinson MB;Hastie AT;Li X;Li H;Moore WC;Howard TD;Busse WW;Erzurum SC;Wenzel SE;Peters SP;Meyers DA;Bleecker ER;National Heart, Lung, and Blood Institute–sponsored Severe Asthma Research Program (SARP)
通讯作者:
National Heart, Lung, and Blood Institute–sponsored Severe Asthma Research Program (SARP)